243 related articles for article (PubMed ID: 25912843)
21. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M
Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670
[TBL] [Abstract][Full Text] [Related]
22. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
23. Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography.
Li SJ; Guo W; Ren GX; Huang G; Chen T; Song SL
Br J Oral Maxillofac Surg; 2008 Apr; 46(3):180-186. PubMed ID: 18093707
[TBL] [Abstract][Full Text] [Related]
24. Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the
Takahashi Y; Sato S; Ishitobi H; Nagaoka M; Kobayashi Y; Fukuhara H; Yuki M; Komazawa Y; Kuroda H; Shizuku T
Intern Med; 2017 Nov; 56(22):3027-3031. PubMed ID: 28943569
[TBL] [Abstract][Full Text] [Related]
25. Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis.
Hu JH; Tang JH; Lin CH; Chu YY; Liu NJ
J Investig Med; 2018 Jan; 66(1):52-61. PubMed ID: 28912249
[TBL] [Abstract][Full Text] [Related]
26. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
Gu J; Yamamoto H; Fukunaga H; Danno K; Takemasa I; Ikeda M; Tatsumi M; Sekimoto M; Hatazawa J; Nishimura T; Monden M
Dig Dis Sci; 2006 Dec; 51(12):2198-205. PubMed ID: 17080242
[TBL] [Abstract][Full Text] [Related]
27. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
Paudyal B; Paudyal P; Oriuchi N; Tsushima Y; Nakajima T; Endo K
Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368
[TBL] [Abstract][Full Text] [Related]
28. Primary tumor maximum standardized uptake value measured on 18F-fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer.
Lee JY; Kim HJ; Yim SH; Shin DS; Yu JH; Ju DY; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2013 Oct; 62(4):227-33. PubMed ID: 24162710
[TBL] [Abstract][Full Text] [Related]
29. High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-D-glucose uptake.
Nguyen XC; So Y; Chung JH; Lee WW; Park SY; Kim SE
Eur J Cancer; 2008 Mar; 44(5):692-8. PubMed ID: 18314327
[TBL] [Abstract][Full Text] [Related]
30. Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
Kitasato Y; Yasunaga M; Okuda K; Kinoshita H; Tanaka H; Okabe Y; Kawahara A; Kage M; Kaida H; Ishibashi M
Pancreas; 2014 Oct; 43(7):1060-5. PubMed ID: 25121413
[TBL] [Abstract][Full Text] [Related]
31. Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.
Jiang L; Tan H; Panje CM; Yu H; Xiu Y; Shi H
Clin Nucl Med; 2016 Jan; 41(1):1-7. PubMed ID: 26402131
[TBL] [Abstract][Full Text] [Related]
32. Biological correlation of ¹⁸F-FDG uptake on PET in pulmonary neuroendocrine tumors.
Kaira K; Murakami H; Endo M; Ohde Y; Naito T; Kondo H; Nakajima T; Yamamoto N; Takahashi T
Anticancer Res; 2013 Oct; 33(10):4219-28. PubMed ID: 24122985
[TBL] [Abstract][Full Text] [Related]
33. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK
Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454
[TBL] [Abstract][Full Text] [Related]
34. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT.
Li J; Kuehl H; Grabellus F; Müller SP; Radunz S; Antoch G; Nadalin S; Broelsch CE; Gerken G; Paul A; Kaiser GM
J Surg Oncol; 2008 Nov; 98(6):438-43. PubMed ID: 18767120
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Glycolytic Response to Multiple Classes of Anti-glioblastoma Drugs by Noninvasive Measurement of Pyruvate Kinase M2 Using [
Beinat C; Patel CB; Xie Y; Gambhir SS
Mol Imaging Biol; 2020 Feb; 22(1):124-133. PubMed ID: 30989436
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte colony-stimulating factor-producing cholangiocellular carcinoma.
Suzumura K; Iimuro Y; Hirano T; Asano Y; Kuroda N; Okada T; Tanaka S; Nakasho K; Fujimoto J
Int Surg; 2015 Jan; 100(1):123-7. PubMed ID: 25594651
[TBL] [Abstract][Full Text] [Related]
37. Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.
Li YC; Yang CS; Zhou WL; Li HS; Han YJ; Wang QS; Wu HB
World J Gastroenterol; 2018 Jan; 24(4):494-503. PubMed ID: 29398870
[TBL] [Abstract][Full Text] [Related]
38. [Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography].
Keiding S; Hansen SB; Rasmussen HH; Gee A; Kruse A; Roelsgaard K; Tage-Jensen U; Dahlerup JF
Ugeskr Laeger; 2000 Feb; 162(6):782-5. PubMed ID: 10689952
[TBL] [Abstract][Full Text] [Related]
39. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
[TBL] [Abstract][Full Text] [Related]
40. Change in total lesion glycolysis and clinical outcome after (90)Y radioembolization in intrahepatic cholangiocarcinoma.
Filippi L; Pelle G; Cianni R; Scopinaro F; Bagni O
Nucl Med Biol; 2015 Jan; 42(1):59-64. PubMed ID: 25213104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
